Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2006 | |
| Sales | 12,019 | 1,480 | 803 | 106 | 0 |
| Cost of Goods | 1,104 | 0 | 0 | N/A | N/A |
| Gross Profit | 10,915 | 1,480 | 803 | 106 | N/A |
| Operating Expenses | 72,939 | 43,649 | 38,555 | 40,229 | 0 |
| Operating Income | -61,920 | -42,169 | -37,752 | -40,123 | N/A |
| Interest Expense | 7,849 | 3,575 | 1,866 | 0 | 0 |
| Other Income | -22,504 | -540 | 148 | 649 | 0 |
| Pre-tax Income | -92,273 | -46,284 | -39,470 | -39,474 | 0 |
| Income Tax | 0 | N/A | -16,245 | -399 | N/A |
| Net Income Continuous | -92,273 | -46,284 | -23,225 | -39,075 | N/A |
| Net Income Discontinuous | N/A | N/A | 77,040 | 612 | N/A |
| Net Income | $-92,273 | $-46,284 | $53,815 | $-38,463 | $N/A |
| EPS Basic Total Ops | -2.90 | -2.72 | 31.39 | -26.38 | N/A |
| EPS Basic Continuous Ops | -2.90 | -2.65 | -16.60 | -26.77 | N/A |
| EPS Basic Discontinuous Ops | N/A | N/A | 47.99 | 0.39 | N/A |
| EPS Diluted Total Ops | -2.90 | -2.72 | 31.39 | -26.38 | N/A |
| EPS Diluted Continuous Ops | -2.90 | -2.65 | -16.60 | -26.77 | N/A |
| EPS Diluted Discontinuous Ops | N/A | N/A | 47.99 | 0.39 | N/A |
| EBITDA(a) | $-58,145 | $-40,968 | $-36,655 | $-38,935 | $N/A |